• Tue
  • Oct 21, 2014
  • Updated: 6:44pm

Shanghai Fosun Pharmaceutical

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a unit of one of China’s largest conglomerates Fosun International. Already listed in Shanghai, the group plans to raise about US$512 million through an initial public offering in November 2012, and said it would use about half the proceeds for domestic and international acquisitions, and the rest for research and development and to pay down debt.

The making of tycoon Guo Guangchang

When three graduates from Shanghai's prestigious Fudan University set up a small venture about two decades ago, they probably never expected the company would become an icon of the mainland's fast-growing private businesses sector.

Wednesday, 7 November, 2012, 11:18am

Uncertain investors drop Fosun Pharma shares on first day

Shares of Shanghai Fosun Pharmaceutical, a generic drug maker, closed 8 per cent below the initial public offer price on the first day of trading, as investors shunned the company's aggressive growth strategy.

31 Oct 2012 - 4:11am

Fosun comes in at low end of range

Shanghai Fosun Pharmaceutical, controlled by billionaire Guo Guangchang, has raised US$512 million (HK$3.9 billion) from its initial public offering in Hong Kong.

25 Oct 2012 - 4:53am

Business Digest, October 23, 2012

Nexen dives as hopes dim for CNOOC deal

23 Oct 2012 - 4:20am

Late, and a few dollars short

Last week, I wrote about the delay in the launch of Shanghai Fosun Pharmaceutical's equity offering in Hong Kong. As expected at the time, book building finally started on October 16 for what is an accelerated timetable (owing to the upcoming bank holiday) that will now see pricing on October 24, and listing and start of trading on October 30.

22 Oct 2012 - 1:54am

Generic drugs firm to grow sideways

Shanghai Fosun Pharmaceutical, a unit of mainland conglomerate Fosun International, said it plans to grow horizontally through acquisitions of drug makers that offer synergies with its products.

17 Oct 2012 - 2:50am

Fosun Pharmaceutical begins taking IPO orders from big investors

Shanghai Fosun Pharmaceutical will start taking orders from institutional investors today in a bid to raise up to US$593 million through a much-delayed initial public offering.

16 Oct 2012 - 4:03am

IPOs: It's all about timing

Shanghai Fosun Pharmaceutical last week pushed back the launch of its US$600 million initial public offering from October 11 to, most likely, today - possibly putting it on track for an accelerated marketing. (See "Take your guess for Fosun Pharma pricing", Money Post, April 30).

15 Oct 2012 - 1:02am

Fosun set to tap HK stock market for US$600m

Shanghai Fosun Pharmaceutical (Group), controlled by Guo Guangchang, is poised to snap a drought of new listings in Hong Kong.

6 Oct 2012 - 10:06am